Alyeska Investment Group
FCSC

Alyeska Investment Group’s Fibrocell Science Inc. FCSC Stock Holding History

Alyeska Investment Group’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-16,667
Closed -$1.09M – 402
2013
Q3 		$1.09M Buy
+16,667
New +$1.35M 0.04% 254

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alyeska Investment Group's FCSC Position: Q4 2013 in Review

Alyeska Investment Group sold out of Fibrocell Science Inc. (FCSC) in Q4 2013, closing a stake of 16,667 shares — an estimated $1.09M sold.

Alyeska Investment Group first reported a position in FCSC in Q3 2013 and held it in 1 quarter. The position peaked at $1.09M in Q3 2013. 43 funds tracked by Wall St. Rank hold FCSC as of Q4 2013.

  • Alyeska Investment Group reported no remaining Fibrocell Science Inc. position as of Q4 2013 after selling out during the quarter.
  • Alyeska Investment Group sold 16,667 Fibrocell Science Inc. shares in Q4 2013, an estimated $1.09M.
  • Alyeska Investment Group first reported a position in Fibrocell Science Inc. in Q3 2013 and held it in 1 quarter.
  • Alyeska Investment Group's Fibrocell Science Inc. position peaked at $1.09M in Q3 2013.
  • 43 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2013.

Based on Alyeska Investment Group's 13F filing for Q4 2013, filed 14 Feb 2014.